| Literature DB >> 32046257 |
Alicja Nowak1, Monika Dalz1, Ewa Śliwicka2, Helena Elegańczyk-Kot3, Jakub Kryściak2, Katarzyna Domaszewska2, Maria Laurentowska2, Piotr Kocur4, Barbara Pospieszna5.
Abstract
The purpose of this study was to assess the effect of Nordic walking training on the indices of bone and carbohydrate metabolism in relation to 25(OH)D levels in postmenopausal women that were subjected to the outdoor systematic physical activity. The study was performed in 10 postmenopausal women, who participated in a 12-week Nordic walking exercise program, taking place during spring months (March to June). Anthropometric and biochemical parameters were measured before and after the training program. Serum concentrations of 25-hydroksycholekalciferol (25(OH)D), parathyroid hormone (PTH), insulin, glucose, osteocalcin (OC), C-terminal telopeptide of type I collagen (CTX), and calcium were determined. After the Nordic walking exercise program, a significant increase in the serum levels of 25(OH)D and CTX and a decrease in body mass, body mass index (BMI), fat mass, and PTH concentrations were observed. The findings of the present study suggest that 25(OH)D, as important metabolic regulator, plays a role in the modification of bone markers' responses after the outdoor training program, independent of the physical activity effects.Entities:
Keywords: Nordic Walking; bone turnover markers; carbohydrates metabolism; vitamin D
Year: 2020 PMID: 32046257 PMCID: PMC7037101 DOI: 10.3390/ijerph17031074
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Somatic characteristics and biochemical indices of women subjected to a 12-week aerobic training program.
| Indicator | Before Training | After Training | |
|---|---|---|---|
| Body mass (kg) | 65.2 (8.89); 66.3 (62.0–72.0) | 63.6 (9.28); 65.3 (59.5–71.0) | 0.0026 |
| BMI (kg/m2) | 25.1 (2.54); 25.5 (24.4–26.5) | 24.5 (2.66); 24.5 (23.5–26.1) | 0.0030 |
| Fat mass (%) | 27.5 (5.24); 28.5 (24.3–30.5) | 25.6 (5.59); 26.0 (22.1–29.4) | 0.0137 |
| Glucose (mmol/L) | 5.0 (1.48); 4.7 (4.2–5.1) | 4.9 (0.73); 5.0 (4.3–5.3) | 0.6465 |
| Insulin (µIU/mL) | 8.9 (2.50); 9.0 (7.2–10.9) | 7.9 (2.13); 7.8 (6.7–9.4) | 0.0908 |
| HOMAIR | 1.8 (0.85); 1.8 (1.4–2.4) | 1.7 (0.59); 1.8 (1.3–2.2) | 0.2578 |
| 25(OH)D (ng/mL) | 18.6 (13.20); 11.7 (10.5–32.2) | 40.4 (9.62); 40.1 (32.0–48.5) | 0.0069 |
| PTH (pg/mL) | 48.1 (10,62); 51.3 (41.2–54.1) | 42.2 (11.37); 43.3 (31.0–50.8) | 0.0411 |
| Ca (mmol/L) | 1.4 (0.12); 1.4 (1.4–1.5) | 1.6 (0.25); 1.6 (1.4–1.8) | 0.2429 |
| OC (ng/mL) | 8.9 (2.96); 7.9 (7.2–11.7) | 8.8 (3.15); 9.0 (7.3–10.7) | 0.9255 |
| CTX (ng/mL) | 0.6 (0.28); 0.6 (0.4–0.7) | 0.7 (0.35); 0.6 (0.5–0.7) | 0.0469 |
| OC/CTX | 15.9 (3.61); 16.2 (13.0–17.8) | 13.8 (3.65); 13.5 (11.8–15.7) | 0.2263 |
Results are expressed as mean (SD); median (interquartile range). BMI body mass index, HOMA homeostatic model assessment of insulin resistance index, 25(OH)D 25-hydroksycholekalciferol, PTH parathyroid hormone, OC osteocalcin, CTX C-terminal telopeptide of type I collagen.